Product NDC: | 0245-0212 |
Proprietary Name: | Midodrine Hydrochloride |
Non Proprietary Name: | midodrine hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; midodrine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0245-0212 |
Labeler Name: | Upsher-Smith Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076725 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041103 |
Package NDC: | 0245-0212-11 |
Package Description: | 100 TABLET in 1 BOTTLE (0245-0212-11) |
NDC Code | 0245-0212-11 |
Proprietary Name | Midodrine Hydrochloride |
Package Description | 100 TABLET in 1 BOTTLE (0245-0212-11) |
Product NDC | 0245-0212 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | midodrine hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20041103 |
Marketing Category Name | ANDA |
Labeler Name | Upsher-Smith Laboratories Inc. |
Substance Name | MIDODRINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |